(RTTNews) - Indian shares were a tad lower on Thursday as IT stocks extended their slide from the previous session on renewed concerns about the disruption AI start-ups will have on established companies. The benchmark BSE Sensex was down 299 points, or 0.4 percent, at 83,934 in early trade while the broader NSE Nifty index dropped by 85 points, or 0.3 percent, to 25,869. HCL Technologies, TCS, Te...
(RTTNews) - Indian shares were a tad lower on Thursday as IT stocks extended their slide from the previous session on renewed concerns about the disruption AI start-ups will have on established companies. The benchmark BSE Sensex was down 299 points, or 0.4 percent, at 83,934 in early trade while the broader NSE Nifty index dropped by 85 points, or 0.3 percent, to 25,869. HCL Technologies, TCS, Tech Mahindra and Infosys were down 3-5 percent. Federal Bank fell nearly 1 percent as the RBI approved ICICI Prudential AMC and ICICI Bank group entities to acquire up to 9.95 percent stake in the bank. Similarly, Equitas Small Fin Bank declined 1.4 percent after the RBI approved and ICICI Pru AMC and ICICI Group Companies to acquire up to 9.95 percent stake in the bank. Netweb Technologies tumbled 2.6 percent on reports its promoters — Sanjay Lodha, Navin Lodha, Niraj Lodha, and Vivek Lodha — are likely to sell up to a 3 percent stake in the company. ONGC rose about 1 percent ahead of its earnings release. Kernex Microsystems rallied 2.2 percent on securing a Rs. 411 crore order from Banaras Locomotive Works to supply 505 Kavach Loco Equipment. Acutaas Chemicals added 1 percent after its arm acquired a 75 percent stake in the JV company, Indichem Incr. Hindalco Industries dropped half a percent after informing the exchanges of a fire incident at its Novelis subsidiary's Oswego plant. Lenskart Solutions soared 9 percent on posting a multi-fold jump in its Q3 net profit. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Lenovo Group ADR press release ( LNVGY ): Q3 GAAP EPS of $0.04. Revenue of $22.2B (+18.1% Y/Y) beats by $1.56B . Excluding non-operating non-cash items and one-time gains and charges in Q3 FY24/25 and Q3 FY25/26, adjusted net income (profit attributable to equity holders – non-HKFRS) increased by 36% year-on-year to US$589 million, with adjusted net income margin [1] expanding to 2.7%. More on Len...
Lenovo Group ADR press release ( LNVGY ): Q3 GAAP EPS of $0.04. Revenue of $22.2B (+18.1% Y/Y) beats by $1.56B . Excluding non-operating non-cash items and one-time gains and charges in Q3 FY24/25 and Q3 FY25/26, adjusted net income (profit attributable to equity holders – non-HKFRS) increased by 36% year-on-year to US$589 million, with adjusted net income margin [1] expanding to 2.7%. More on Lenovo Group ADR Lenovo: Undervalued, But Surging Memory Prices Threaten Margins And End-User Demand Lenovo: Still A 'Buy' With Earnings Surprise And Positive Outlook Lenovo Group Limited (LNVGY) Q2 2026 Earnings Call Transcript ClearBridge International Growth EAFE Strategy exits Novo Nordisk, adds Roche in Q4 Global PC shipments rose 9% in 2025; supply constraints cloud 2026 outlook
On February 12, 2026, semiconductor stocks surged across global markets, fueled by a potent mix of strong earnings, upbeat forecasts, and a wave of investor optimism following Micron Technology’s standout performance on Wall Street. As the sun rose on the Korean financial landscape, local semiconductor giants like Samsung Electronics and SK Hynix found themselves riding a wave of momentum that beg...
On February 12, 2026, semiconductor stocks surged across global markets, fueled by a potent mix of strong earnings, upbeat forecasts, and a wave of investor optimism following Micron Technology’s standout performance on Wall Street. As the sun rose on the Korean financial landscape, local semiconductor giants like Samsung Electronics and SK Hynix found themselves riding a wave of momentum that began hours earlier in New York, where Micron’s stock price had soared nearly 10% in a single session. The catalyst? According to Hana Securities, the answer lies in both the numbers and the narrative. On February 11, 2026 (local US time), Micron’s Chief Financial Officer Mark Murphy took the stage at the Wolfe Research Conference to announce that shipments of the company’s next-generation high-bandwidth memory, HBM4, had officially begun. Murphy went further, addressing swirling rumors about Micron’s role in Nvidia’s supply chain: “Reports claiming exclusion from Nvidia’s next-gen supply chain were inaccurate,” he stated, firmly dispelling recent speculation. He emphasized that HBM4 was now in mass production and that shipments to customers had started a full year ahead of schedule—a move that sent a clear signal to the market about Micron’s operational prowess and strategic positioning. The market’s response was immediate and emphatic. As reported by TopStarNews, Micron’s stock closed at $410.34, up 9.94% from the previous day’s closing price of $373.25. The trading day saw the stock range from a low of $386.57 to a high of $414.16, with more than 47 million shares changing hands—reflecting a staggering $19.1 billion in trading value. The company’s market capitalization reached $461.8 billion, a testament to its growing clout in the semiconductor sector. After the closing bell, the momentum continued, with shares climbing an additional 1.25% in after-hours trading to $415.48. It wasn’t just Micron basking in the glow. The positive sentiment radiated outward, energizing semic...
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Amazon.com Inc. (NASDAQ:AMZN) founder Jeff Bezos posted an image of a turtle on Monday, tagging his space company Blue Origin, drawing a swift response from SpaceX CEO Elon Musk. Musk’s Response Musk replied to Bezos’ post with “Turtle heading?” and added, “When it’s coming out slowly, but ferociously.” When it's coming out slowly, but ferociously The exchange references the classic fable of the t...
Amazon.com Inc. (NASDAQ:AMZN) founder Jeff Bezos posted an image of a turtle on Monday, tagging his space company Blue Origin, drawing a swift response from SpaceX CEO Elon Musk. Musk’s Response Musk replied to Bezos’ post with “Turtle heading?” and added, “When it’s coming out slowly, but ferociously.” When it's coming out slowly, but ferociously The exchange references the classic fable of the tortoise and the hare, where steady progress defeats overconfidence. Don't Miss: Missed Nvidia and Tesla? RAD Intel Could Be the Next AI Powerhouse — Just $0.85 a Share This investment firm leverages expert insights and a 2.40x net equity multiple to help accredited investors capitalize on 2026 multifamily market trends—read the full forecast now. SpaceX Pivots To Lunar Focus The social media exchange came after Musk announced on Monday that SpaceX has shifted its primary focus from Mars to building a self-sustaining city on the Moon. “For those unaware, SpaceX has already shifted focus to building a self-growing city on the Moon, as we can potentially achieve that in less than 10 years, whereas Mars would take 20+ years,” Musk wrote on X. Musk explained that Mars missions are only possible every 26 months with a six-month travel time, while lunar missions can launch every 10 days with a two-day journey. “This means we can iterate much faster to complete a Moon city than a Mars city,” he said. Trending: It’s no wonder Jeff Bezos holds over $250 million in art — this alternative asset has outpaced the S&P 500 since 1995, delivering an average annual return of 11.4%. Here’s how everyday investors are getting started. The SpaceX CEO added that the company will still pursue Mars colonization beginning in five to seven years, but the Moon remains the “overriding priority” for “securing the future of civilization.” For those unaware, SpaceX has already shifted focus to building a self-growing city on the Moon, as we can potentially achieve that in less than 10 years, whereas Mars ...
Shopify continues to grow its revenue at a rapid rate. But is the stock overvalued? E-commerce specialist Shopify (SHOP 6.70%) saw its shares take a hit on Wednesday following its latest earnings report. While revenue for its fourth quarter came in ahead of analysts' consensus forecast for the period, it marked a deceleration from its Q3 growth rate. During a period when many investors are expecti...
Shopify continues to grow its revenue at a rapid rate. But is the stock overvalued? E-commerce specialist Shopify (SHOP 6.70%) saw its shares take a hit on Wednesday following its latest earnings report. While revenue for its fourth quarter came in ahead of analysts' consensus forecast for the period, it marked a deceleration from its Q3 growth rate. During a period when many investors are expecting accelerated growth as companies integrate AI (artificial intelligence) into their businesses, the market may have been hoping for stronger growth than Wall Street analysts were. But some investors may be wondering whether the tech stock's 6.7% decline on Wednesday went too far, potentially creating a buying opportunity. After all, it adds to an already difficult year for the growth stock. Unfortunately, I think shares remain overvalued, even after a more than 26% decline already in 2026. Here's a closer look at why I'm not buying the dip in Shopify's stock price. Strong fourth-quarter results Just because I don't like the stock doesn't mean I can't like the business. And Shopify's fourth-quarter results continued to show a company firing on all cylinders. Shopify's fourth-quarter revenue grew at an explosive rate, climbing 31% year over year. Additionally, its bottom-line performance was impressive. Net income, when excluding the impact of equity investments, rose about 30% year over year during the period. And free cash flow, which represents its cash flow from operations less capital expenditures, remains a strength for Shopify. The company's free cash flow rose 17% year over year to $715 million. That translated into an impressive 19% free cash flow margin. And on a full-year basis, Shopify's free cash flow rose 26% year over year to more than $2 billion. With strong free cash flow and no debt on its balance sheet, Shopify launched a massive share repurchase program, authorizing up to $2 billion to buy back its own stock. "We are launching this share repurchase progra...
Victor Golmer Novo Nordisk ( NVO ) aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers it’s lost to rival Eli Lilly & Co. ( LLY ), Bloomberg News reported. Currently Novo sells the drug in plastic injector pens. Rival Lilly launched vials nearly two years ago to offer a lower-priced version of its shot and alleviate shortages. It’s unclear what ...
Victor Golmer Novo Nordisk ( NVO ) aims to start selling its weight-loss blockbuster Wegovy in vials, its latest move to win over customers it’s lost to rival Eli Lilly & Co. ( LLY ), Bloomberg News reported. Currently Novo sells the drug in plastic injector pens. Rival Lilly launched vials nearly two years ago to offer a lower-priced version of its shot and alleviate shortages. It’s unclear what Novo ( NVO ) will charge for vials, but the company has already been aggressively discounting its obesity drugs to compete, the report added. Lilly ( LLY ) last year cut the price for vials of Zepbound by $50 or more and expanded the range of doses sold online. More on Novo Nordisk A/S, Eli Lilly Novo Nordisk: How Low Is Too Low? (Downgrade, Technical Analysis) Novo Nordisk: Ugly Guidance, But Stock Refuses To Break Down Further Novo Nordisk: Full Kitchen Sink Reset Or Another Shoe Yet To Drop? Eli Lilly gains approval of mirikizumab in China for bowel diseases Hengrui, Kailera phase 2 obesity pill results could pressure Eli Lilly's orforglipron